SARAH FITZSIMMONS: Open Payments
NPI 1053662650 · STURGIS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$168 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $31 · 2025 $168
Food & beverage: $168
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| Novo Nordisk Inc | 2 | $32 |
| Amgen Inc. | 2 | $29 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| PFIZER INC. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: LEQVIO, EVENITY, M-M-R II, PREVNAR 20, MOUNJARO, Ozempic, Rybelsus, FARXIGA.
Industry payments across SD — which companies pay providers there.
